Abu Dzarr Abdullah
Overview
Explore the profile of Abu Dzarr Abdullah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zahidin M, Noor N, Johan M, Abdullah A, Zulkafli Z, Edinur H
Sci Data
. 2025 Jan;
12(1):28.
PMID: 39774005
No abstract available.
2.
Zahidin M, Noor N, Johan M, Abdullah A, Zulkafli Z, Edinur H
Sci Data
. 2024 Apr;
11(1):435.
PMID: 38688916
The human mannose-binding lectin (MBL) gene encodes a polymorphic protein that plays a crucial role in the innate immune response. Human MBL deficiency is associated with immunodeficiencies, and its variants...
3.
Zahidin M, Abdul Razak N, Noor N, Johan M, Zulkafli Z, Abdullah A, et al.
Cureus
. 2023 Dec;
15(11):e48533.
PMID: 38073971
Immune thrombocytopenia (ITP) has been comprehensively studied and understood in Western Europe and various Asia-Pacific regions. However, the epidemiological and clinical-laboratory aspects of ITP in Malaysia remain limited and not...
4.
Zahidin M, Noor N, Johan M, Abdullah A, Zulkafli Z, Edinur H
Healthcare (Basel)
. 2022 Jan;
10(1).
PMID: 35052202
Immune thrombocytopenia (ITP) is an acquired autoimmune disease that occurs in adults and children. In Malaysia, the clinical practice guideline (CPG) for the management of ITP was issued in 2006,...
5.
Hanafi H, Husin A, Yaacob N, Abdullah A
Malays J Med Sci
. 2020 Nov;
27(5):62-77.
PMID: 33154703
Background: Some multiple myeloma (MM) patients still relapse/progress despite novel agent therapy and relapse/progression in MM is therefore a vital area of ongoing research in the novel treatment era. This...
6.
Nik Man N, Hassan R, Ang C, Abdullah A, Mohd Radzi M, Sulaiman S
Biomed Res Int
. 2015 Nov;
2015:307094.
PMID: 26613081
Complementary medicine using natural product as antitumor is on the rise. Much research has been performed on Tualang Honey and it was shown to have therapeutic potential in wound healing,...
7.
Zueter A, Mohamed Z, Abdullah A, Mohamad N, Arifin N, Othman N, et al.
Singapore Med J
. 2014 Aug;
55(7):367-71.
PMID: 25091885
Introduction: Strongyloidiasis is one of the most commonly neglected but clinically important parasitic infections worldwide, especially among immunocompromised patients. Evidence of infection among immunocompromised patients in Malaysia is, however, lacking....
8.
Elias M, Baba A, Husin A, Abdullah A, Hassan R, Ai Sim G, et al.
Hematol Rep
. 2013 Jan;
4(4):e23.
PMID: 23355941
Development of resistance to imatinib mesylate (IM) in chronic myeloid leukemia (CML) patients is mediated by different mechanisms that can be classified as BCR-ABL dependent or BCR-ABL independent pathways. BCR-ABL...